Proliferin-3 Inhibitors
Chemical inhibitors of Proliferin-3 can impact its function by targeting various signaling pathways and enzymes that are crucial for its activity. Acetazolamide, through its inhibition of carbonic anhydrase, can alter the pH balance within tissues, which in turn can affect the activity of Proliferin-3 if its function is pH-sensitive. AG-490, a tyrosine kinase inhibitor, can disrupt the JAK/STAT signaling pathway, which is often involved in promoting cell proliferation. Inhibition by AG-490 can therefore interfere with the proliferative actions mediated by Proliferin-3. Similarly, LY294002 and Wortmannin, both PI3K inhibitors, can suppress the PI3K/AKT signaling pathway. Since this pathway is integral to cell growth and survival, the action of these inhibitors can lead to a reduction in Proliferin-3 activity by preventing the signaling required for its function in cell proliferation.
Further, PD98059 and U0126, which inhibit MEK, and consequently the MAPK/ERK pathway, can impede the signaling cascade that is necessary for cell division and proliferation where Proliferin-3 is involved. Rapamycin, targeting the mTOR within the same PI3K/AKT/mTOR pathway, can also suppress the cell growth and proliferation that Proliferin-3 promotes. SB203580, by inhibiting p38 MAP kinase, can interfere with the stress response and cell cycle regulation, possibly reducing the supportive role Proliferin-3 plays in cell survival and proliferation under these conditions. SP600125, as an inhibitor of JNK, can affect apoptosis and cell proliferation, thereby impacting Proliferin-3 activity that is associated with these processes. Triciribine specifically inhibits AKT activation, which is central to the PI3K/AKT/mTOR pathway, thus leading to decreased cell survival and proliferation signals that Proliferin-3 may enhance.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Acetazolamide | 59-66-5 | sc-214461 sc-214461A sc-214461B sc-214461C sc-214461D sc-214461E sc-214461F | 10 g 25 g 100 g 250 g 500 g 1 kg 2 kg | $81.00 $177.00 $434.00 $541.00 $883.00 $1479.00 $2244.00 | 1 | |
Acetazolamide inhibits carbonic anhydrase, which is involved in pH regulation. Proliferin-3 is sensitive to pH changes, as the reproductive and angiogenic processes it influences are pH-dependent. Inhibition of carbonic anhydrase alters the tissue pH, which can lead to reduced Proliferin-3 activity due to its pH sensitivity. | ||||||
AG-490 | 133550-30-8 | sc-202046C sc-202046A sc-202046B sc-202046 | 5 mg 50 mg 25 mg 10 mg | $84.00 $329.00 $223.00 $87.00 | 35 | |
AG-490 is a tyrosine kinase inhibitor that targets the JAK/STAT pathway, which is crucial for cell growth and differentiation. Proliferin-3 is involved in cell proliferation; inhibiting the JAK/STAT pathway can decrease cellular responses to growth signals, thereby inhibiting Proliferin-3's role in promoting proliferation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K, a key enzyme in the PI3K/AKT/mTOR signaling pathway that is known to regulate cell growth and survival. By blocking PI3K, LY294002 can inhibit the downstream signaling that Proliferin-3 might influence to promote cell proliferation and survival, thereby inhibiting its function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, which is part of the MAPK/ERK pathway, a pathway that affects cell division and proliferation. Proliferin-3, being associated with cell growth, would have its function inhibited as MEK inhibition by PD98059 leads to the suppression of the MAPK/ERK signaling, thus reducing proliferation that Proliferin-3 would normally promote. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a central protein in the PI3K/AKT/mTOR signaling pathway. By inhibiting mTOR, Rapamycin can suppress cell growth and proliferation, processes in which Proliferin-3 is implicated. This inhibition directly reduces the proliferative effects that Proliferin-3 can have on cells. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAP kinase, which is involved in the response to stress stimuli and is also implicated in cell cycle regulation. By inhibiting p38 MAP kinase, SB203580 can dampen the cellular stress responses and interfere with cell cycle regulation, thereby inhibiting the role of Proliferin-3 in promoting cell survival and proliferation under stress conditions. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, preventing the activation of the MAPK/ERK pathway. Since Proliferin-3 is involved in proliferative signaling, the inhibition of this pathway by U0126 would lead to a decrease in cell proliferation and differentiation signals, thereby inhibiting the functional role of Proliferin-3. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor that can suppress the PI3K/AKT signaling pathway, which is involved in controlling cell growth and proliferation. Inhibition of this pathway by Wortmannin would reduce the signaling that could be enhanced by Proliferin-3, thereby inhibiting its role in promoting cell growth and proliferation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is a protein kinase that regulates apoptosis, cell proliferation, and differentiation. Inhibiting JNK with SP600125 can reduce the proliferative signals that Proliferin-3 is known to promote, thus inhibiting its function in the process of cell growth and survival. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine specifically inhibits the activation of AKT, a key player in the PI3K/AKT/mTOR pathway. By inhibiting AKT, Triciribine can decrease the survival and proliferation of cells that Proliferin-3 would normally support, thereby functionally inhibiting the biological effects of Proliferin-3. | ||||||